But, increasing evidence shows that they act a role in gene expression and regulation, RNA processing and translation in human diseases including cancer.4, 5 NEAT1 as a nuclear‐restricted lncRNA was thought to promote myeloid differentiation in acute promyelocytic leukaemia6 and androgen receptor‐associated prostate cancer progression.7 Subsequently, NEAT is responsible for reducing chemotherapy sensitivity8, 9 and accelerating tumorigenesis in breast cancer,10 ovarian cancer11 and bladder cancer,12 acting as a potential prognostic predictor of glioma.13 Here, NEAT1 is linked to central nervous system cancer.